Monday, June 17, 2024
HomeTagsTysabri

Tysabri

FDA Approves First Biosimilar to Treat Multiple Sclerosis

The U.S. Food and Drug Administration approved Tyruko, the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing forms of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics